🇺🇸 FDA
Patent

US 9821049

Method of conferring a protective immune response to Norovirus

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 9821049 (Method of conferring a protective immune response to Norovirus) held by Takeda Vaccines, Inc. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55572, A61K2039/57